Treatment of patients who have severe mitral
regurgitation (MR) and tricuspid regurgitation (TR) is
surgical repair or replacement. However, it becomes a
therapeutic challenge in patients who are at prohibitive
surgical risk. In such patients, percutaneous edge-to-edge
repair of mitral valve with the MitraClip system (Abbott
Vascular, Santa Clara, CA, USA) has demonstrated
its clinical efficacy and safety. For the tricuspid valve,
various percutaneous techniques are emerging rapidly.1
We report a patient in cardiogenic shock from severe
MR and TR who underwent percutaneous repair of
both valves using the MitraClip system. This is the first
successful percutaneous intervention of the tricuspid
valve in Singapore.
This article is available only as a PDF. Please click on “Download PDF” on top to view the full article.